Probiotic Modulation of Oral Microbiota

Plain-language summary

This study looks at how a probiotic product (Probiotics-O) affects the oral microbiota, compared with a placebo. Adults in good oral and general health could take part. It was a study without a phase designation and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Prof. Jacques SCHRENZEL

Intervention

Probiotics-O (Burgerstein), Placebo [inactivated Probiotics-O (Burgerstein)]

Start date

11/1/2021

Estimated completion

10/24/2022

Countries

Switzerland

Related genes

Locations

• Geneva, Switzerland

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Informed Consent as documented by signature
* Good oral and general health

Exclusion Criteria:

* Women who are pregnant or breast feeding
* Intention to become pregnant during the course of the study
* Systemic disease
* Previous enrolment into the current study
* Clinically diagnosed severe oral lesions
* Use of antibiotics and topical oral probiotics within the 3 months preceding the study or during the study
* Dental treatments and use of oral disinfectants within 30 days preceding the study or during the study